March 8 (UPI) -- Researchers at the Mayo Clinic identified an experimental drug that boosts the immune system to fight multiple myeloma.
In a recent study, the drug, LCL161, stimulated the immune system to recognize and attack cancer cells, leading to tumor shrinkage in patients with multiple myeloma.